Back to top
more

NeueHealth, Inc. (NEUE)

(Real Time Quote from BATS)

$6.03 USD

6.03
12,368

-0.39 (-6.08%)

Updated May 9, 2024 02:53 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for NEUE

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for NeueHealth, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 94 480 1,255 988 631
Receivables 39 74 113 61 1
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 956 3,018 292 131 17
Total Current Assets 1,089 3,571 1,660 1,180 649
Net Property & Equipment 15 43 38 12 3
Investments & Advances 0 5 675 175 115
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 93 1,009 1,179 415 39
Deposits & Other Assets 29 37 46 28 14
Total Assets 1,225 4,665 3,598 1,811 820
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 304 304 155 0 0
Accounts Payable 12 68 118 57 33
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 1,075 3,317 2,010 508 117
Total Current Liabilities 1,391 3,689 2,283 565 195
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 66 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 22 37 42 1,710 889
Minority Interest (Liabilities) 1,009 1,140 128 40 0
Total Liabilities 2,489 4,866 2,453 2,314 1,084
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 3,056 2,972 2,861 10 3
Retained Earnings -4,308 -3,156 -1,701 -516 -268
Other Equity 0 -4 -3 2 1
Treasury Stock 12 12 12 0 0
Total Shareholder's Equity -1,264 -200 1,145 -504 -263
Total Liabilities & Shareholder's Equity 1,225 4,665 3,598 1,811 820
Total Common Equity -1,264 -200 1,145 -504 -263
Shares Outstanding 7.90 7.80 7.80 NA NA
Book Value Per Share -159.99 -25.70 146.81 0.01 0.00

Fiscal Year End for NeueHealth, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 94 114 108 395
Receivables NA 39 33 28 125
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 956 1,766 3,716 3,252
Total Current Assets NA 1,089 1,912 3,851 3,771
Net Property & Equipment NA 15 18 18 41
Investments & Advances NA 0 0 0 4
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 93 96 500 1,002
Deposits & Other Assets NA 29 30 23 30
Total Assets NA 1,225 2,056 4,393 4,848
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 304 354 304 304
Accounts Payable NA 12 11 18 34
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 1,075 1,466 3,313 3,674
Total Current Liabilities NA 1,391 1,831 3,635 4,012
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 66 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 31 29 32
Minority Interest (Liabilities) NA 1,009 1,248 1,165 1,144
Total Liabilities NA 2,489 3,109 4,829 5,188
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 3,056 3,038 3,021 3,006
Retained Earnings NA -4,308 -4,078 -3,444 -3,331
Other Equity NA 0 -1 -1 -2
Treasury Stock NA 12 12 12 12
Total Shareholder's Equity NA -1,264 -1,053 -436 -340
Total Liabilities & Shareholder's Equity NA 1,225 2,056 4,393 4,848
Total Common Equity 0 -1,264 -1,053 -436 -340
Shares Outstanding 8.20 7.90 7.90 7.90 7.90
Book Value Per Share 0.00 -159.99 -133.30 -55.15 -43.04